Benitec Biopharma (BNTC) Other Working Capital Changes (2022 - 2025)

Benitec Biopharma has reported Other Working Capital Changes for 7 years, with the latest figure at $195000.0 in Q4 2025.

• Quarterly Other Working Capital Changes rose 400.0% year-over-year to $195000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $315000.0 (up 775.0% YoY) and the FY2025 annual result came in at $111000.0, up 117.21% from the prior year.
• Other Working Capital Changes rose to $195000.0 in Q4 2025 per BNTC's latest filing, from -$156000.0 in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $547000.0 in Q2 2022 and troughed at -$709000.0 in Q3 2023.
• A 5-year average of $14250.0 and a median of -$82500.0 in 2024 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2021 and 2025: Other Working Capital Changes plunged 482.0% in 2021, then surged 400.0% in 2025.
• Over 5 years, Other Working Capital Changes stood at -$291000.0 in 2021, then soared by 42.27% to -$168000.0 in 2022, then increased by 18.45% to -$137000.0 in 2023, then soared by 52.55% to -$65000.0 in 2024, then soared by 400.0% to $195000.0 in 2025.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered $195000.0, -$156000.0, and $258000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.